16 – Structural and Functional Imaging of Cerebral Neoplasia

[1]  K. Leenders,et al.  Effect of radiotherapy on brain glucose metabolism in patients operated on for low grade astrocytoma , 1999, Journal of neurology, neurosurgery, and psychiatry.

[2]  Tomio Inoue,et al.  18F α-methyl tyrosine PET studies in patients with brain tumors , 1999 .

[3]  J. Votaw,et al.  Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  L. Larocca,et al.  Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Berger,et al.  2-[C-11]thymidine imaging of malignant brain tumors. , 1999, Cancer research.

[6]  T. Cloughesy,et al.  Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma , 1999, Magnetic resonance in medicine.

[7]  M Schwaiger,et al.  Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  L. Ketonen,et al.  Imaging of brain tumors in AIDS patients by means of dual-isotope thallium-201 and technetium-99m sestamibi single-photon emission tomography , 1998, European Journal of Nuclear Medicine.

[9]  L. Deangelis,et al.  Malignant glioma: Who benefits from adjuvant chemotherapy? , 1998, Annals of neurology.

[10]  J. Maldjian,et al.  Functional image-guided surgery of intracranial tumors located in or near the sensorimotor cortex. , 1998, Journal of neurosurgery.

[11]  M. Sasaki,et al.  A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours , 1998, European Journal of Nuclear Medicine.

[12]  R. McLendon,et al.  Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  I. Wilkinson,et al.  Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS. , 1998, Sexually transmitted infections.

[14]  M Schwaiger,et al.  The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas. , 1998, International journal of radiation oncology, biology, physics.

[15]  S. Ohta,et al.  [Surgical management for preserving motor function in patients with gliomas near the primary motor cortex: usefulness of preoperative identification of motor cortex and intraoperative monitoring of motor evoked potentials]. , 1998, No shinkei geka. Neurological surgery.

[16]  P. Black,et al.  Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy. , 1998, Journal of neurosurgery.

[17]  L. Kessler,et al.  Thallium-201 brain SPECT of lymphoma in AIDS patients: pitfalls and technique optimization. , 1998, AJNR. American journal of neuroradiology.

[18]  S. Warach,et al.  Magnetic Resonance Imaging of Acute Stroke , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[19]  Karl Herholz,et al.  Localization of Language-Related Cortex with15O-Labeled Water PET in Patients with Gliomas , 1998, NeuroImage.

[20]  F Isamat,et al.  Clinical application of functional magnetic resonance imaging in presurgical identification of the central sulcus. , 1998, Journal of neurosurgery.

[21]  R. P. Maguire,et al.  Dexamethasone treatment and plasma glucose levels: relevance for fluorine-18-fluorodeoxyglucose uptake measurements in gliomas. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  C. Degueldre,et al.  Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  M. Prados,et al.  Survival and functional status after resection of recurrent glioblastoma multiforme. , 1998, Neurosurgery.

[24]  G A Ojemann,et al.  Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  R. Kauppinen,et al.  Monitoring thymidine kinase and ganciclovir-induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging. , 1998, Cancer gene therapy.

[26]  K. Ono,et al.  Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  Jeffrey G. Ojemann,et al.  Increased Functional Vascular Response in the Region of a Glioma , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  T. Hölzer,et al.  The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using f-18-fluorodeoxyglucose and c-11-L-methylmethionine. , 1997, Neurosurgery.

[29]  O. Schober,et al.  Diagnosis of recurrent glioma with SPECT and iodine-123-α-methyl tyrosine , 1998 .

[30]  T A Yousry,et al.  Preoperative activation and intraoperative stimulation of language-related areas in patients with glioma. , 1997, Neurosurgery.

[31]  H Toyama,et al.  Three-dimensional imaging of cortical structure, function and glioma for tumor resection. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  O. Schober,et al.  Iodine-123-alpha-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  N. Lundbom,et al.  Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. , 1997, Journal of Neurosurgery.

[34]  Susan M. Chang,et al.  Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. , 1997, Journal of neurosurgery.

[35]  J. Koudstaal,et al.  Proliferative activity in human brain tumors: comparison of histopathology and L-[1-(11)C]tyrosine PET. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[36]  S. Goldman,et al.  Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  T L Chenevert,et al.  Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[38]  J. Korf,et al.  Positron emission tomography in primary brain tumours using cobalt-55. , 1997, Nuclear medicine communications.

[39]  N. Shinoura,et al.  PET imaging of brain tumor with [methyl-11C]choline. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[40]  Localization of the cortical motor area by functional magnetic resonance imaging with gradient echo and echo-planar methods, using clinical 1.5 Tesla MR imaging systems. , 1997, Osaka city medical journal.

[41]  D. Kinzel,et al.  Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  T Morioka,et al.  Increased activity of the ipsilateral motor cortex during a hand motor task in patients with brain tumor and paresis. , 1997, AJNR. American journal of neuroradiology.

[43]  H. Herzog,et al.  3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[44]  W H Theodore,et al.  A direct comparison of PET activation and electrocortical stimulation mapping for language localization , 1997, Neurology.

[45]  K.,et al.  Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas. , 1997, Journal of neurosurgery.

[46]  N. Shinoura,et al.  Brain tumors: detection with C-11 choline PET. , 1997, Radiology.

[47]  J. Drake,et al.  Combined utility of functional MRI, cortical mapping, and frameless stereotaxy in the resection of lesions in eloquent areas of brain in children. , 1997, Pediatric neurosurgery.

[48]  V. Sturm,et al.  11C-methionine and 18F-2-fluorodeoxyglucose positron emission tomography: a tool for diagnosis of cerebral glioma and monitoring after brachytherapy with 125I seeds. , 1997, Stereotactic and functional neurosurgery.

[49]  I Berry,et al.  Motor functional MRI for presurgical evaluation of cerebral tumors. , 1997, Stereotactic and functional neurosurgery.

[50]  R. Noto,et al.  Single-photon emission CT in the evaluation of recurrent brain tumor in patients treated with gamma knife radiosurgery or conventional radiation therapy. , 1996, AJNR. American journal of neuroradiology.

[51]  T. L. Park,et al.  Glucose metabolic changes in nontumoral brain tissue of patients with brain tumor following radiotherapy: a preliminary study. , 1996, Journal of computer assisted tomography.

[52]  M Leonardi,et al.  Functional MRI: primary motor cortex localization in patients with brain tumors. , 1996, Journal of computer assisted tomography.

[53]  T. Hammeke,et al.  Functional magnetic resonance imaging mapping of the motor cortex in patients with cerebral tumors. , 1996, Neurosurgery.

[54]  S. Goldman,et al.  Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma. , 1996, Neurosurgery.

[55]  J. Scott,et al.  Impact of fluorodeoxyglucose positron emission tomography on the clinical management of patients with glioma. , 1996, Clinical nuclear medicine.

[56]  S. Goldman,et al.  Regional glucose metabolism and histopathology of gliomas: A study based on positron emission tomography‐guided stereotactic biopsy , 1996, Cancer.

[57]  J G Ojemann,et al.  Preserved function in brain invaded by tumor. , 1996, Neurosurgery.

[58]  K Wienhard,et al.  F-Dopa as an amino acid tracer to detect brain tumors. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[59]  U. Mödder,et al.  Mapping of the cortical motor hand area with functional MR imaging and MR imaging-guided laser-induced interstitial thermotherapy of brain tumors. Work in progress. , 1996, Radiology.

[60]  T R Brown,et al.  Metabolism of phosphonium choline by rat-2 fibroblasts: effects of mitogenic stimulation studied using 31P NMR spectroscopy. , 1996, Anticancer research.

[61]  R. Gillies,et al.  Phosphomonoester metabolism as a function of cell proliferative status and exogenous precursors. , 1996, Anticancer research.

[62]  E. Ryding,et al.  Preoperative grading of glioma malignancy with thallium-201 single-photon emission CT: comparison with conventional CT. , 1996, AJNR. American journal of neuroradiology.

[63]  D J Jenden,et al.  In vivo 1H MRS choline: correlation with in vitro chemistry/histology. , 1996, Life sciences.

[64]  G A Ojemann,et al.  Functional cortex and subcortical white matter located within gliomas. , 1996, Neurosurgery.

[65]  T R Brown,et al.  Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. , 1996, Journal of neurosurgery.

[66]  D. Louis Collins,et al.  Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.

[67]  M. Prados,et al.  Radiation response and survival time in patients with glioblastoma multiforme. , 1996, Journal of neurosurgery.

[68]  M. D’Esposito,et al.  Functional magnetic resonance imaging of regional brain activity in patients with intracerebral gliomas: findings and implications for clinical management. , 1996, Neurosurgery.

[69]  I. Kanno,et al.  Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine. , 1996, AJNR. American journal of neuroradiology.

[70]  J. Pipe,et al.  Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. , 1996, British Journal of Cancer.

[71]  M M Haglund,et al.  Enhanced optical imaging of human gliomas and tumor margins. , 1996, Neurosurgery.

[72]  S. Musumeci,et al.  Thallium-201-SPECT and 99Tc-HM-PAO SPECT imaging to study functionally cerebral supratentorial neoplasms: the biological basis of the functional imaging interpretation. , 1995, Journal of neurosurgical sciences.

[73]  M. Oudkerk,et al.  Hydrogen Magnetic Resonance Spectroscopy Follow-up After Radiation Therapy of Human Brain Cancer: Unexpected Inverse Correlation Between the Changes in Tumor Choline Level and Post-Gadolinium Magnetic Resonance Imaging Contrast , 1995, Investigative radiology.

[74]  V. Haughton,et al.  Location of the sensorimotor cortex: functional and conventional MR compared. , 1995, AJNR. American journal of neuroradiology.

[75]  A. Dwyer,et al.  Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids. , 1995, Journal of neurosurgery.

[76]  D. Le Bihan,et al.  Functional MRI during word generation, using conventional equipment , 1995, Neurology.

[77]  M. Mottolese,et al.  Somatostatin receptor imaging in CNS tumours using 111In‐octreotide , 1995, Nuclear medicine communications.

[78]  K. Leenders,et al.  Alteration of blood-brain barrier in human brain tumors: comparison of [18F]fluorodeoxyglucose, [11C]methionine and rubidium-82 using PET , 1995, Journal of the Neurological Sciences.

[79]  A. Matsumura,et al.  Clinical application of diffusion-weighted magnetic resonance imaging to intracranial disorders. , 1995, Neurologia medico-chirurgica.

[80]  D. Jenden,et al.  Localized In Vivo 1H Magnetic Resonance Spectroscopy and In Vitro Analyses of Heterogeneous Brain Tumors , 1995, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[81]  G Tedeschi,et al.  Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging , 1995, Neurology.

[82]  Bruno Alfano,et al.  1H MR Spectroscopy in Patients with Metastatic Brain Tumors: A Multicenter Study , 1995, Magnetic resonance in medicine.

[83]  T. Asakura,et al.  Functional magnetic resonance imaging of the human motor cortex. , 1995, Neurologia medico-chirurgica.

[84]  A. Hercbergs,et al.  A prospective evaluation of thallium-201 single photon emission computerized tomography for brain tumor burden. , 1995, International journal of radiation oncology, biology, physics.

[85]  A. Willemsen,et al.  In vivo protein synthesis rate determination in primary or recurrent brain tumors using L-[1-11C]-tyrosine and PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[86]  A. Luxen,et al.  Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. , 1995, Journal of neurosurgery.

[87]  J G Pipe,et al.  In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. , 1995, AJNR. American journal of neuroradiology.

[88]  A. Bizzi,et al.  Response of non-Hodgkin lymphoma to radiation therapy: early and long-term assessment with H-1 MR spectroscopic imaging. , 1995, Radiology.

[89]  M M Haglund,et al.  Enhanced optical imaging of rat gliomas and tumor margins. , 1994, Neurosurgery.

[90]  T. Cascino,et al.  Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[91]  F Daghighian,et al.  Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridine. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[92]  R. Gillies,et al.  In Vitro and in Vivo 13C and 31P NMR analyses of phosphocholine metabolism in rat glioma cells , 1994, Magnetic resonance in medicine.

[93]  T. Borght,et al.  Brain tumor imaging with PET and 2-[carbon-11]thymidine. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[94]  F. Shishido,et al.  Perfusion and metabolism in predicting the survival of patients with cerebral gliomas , 1994, Cancer.

[95]  D Le Bihan,et al.  Magnetic Resonance Imaging Functional Activation of Left Frontal Cortex During Covert Word Production , 1994, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[96]  J. Mazziotta,et al.  Thallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence. , 1994, Neurological research.

[97]  R D Tien,et al.  MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. , 1994, AJR. American journal of roentgenology.

[98]  C. Jack,et al.  Sensory motor cortex: correlation of presurgical mapping with functional MR imaging and invasive cortical mapping. , 1994, Radiology.

[99]  J H Duyn,et al.  Multisection proton MR spectroscopic imaging of the brain. , 1993, Radiology.

[100]  G. McCarthy,et al.  Echo-planar magnetic resonance imaging studies of frontal cortex activation during word generation in humans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[101]  H. Fine,et al.  Meta‐analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults , 1993, Cancer.

[102]  J. Cairncross,et al.  Malignant glioma--timing of response to radiation therapy. , 1993, International journal of radiation oncology, biology, physics.

[103]  D. Saunders,et al.  Proton spectroscopy in vivo. , 1993, Magnetic resonance quarterly.

[104]  J Hennig,et al.  Human brain tumors: assessment with in vivo proton MR spectroscopy. , 1993, Radiology.

[105]  J A Frank,et al.  Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. , 1992, Radiology.

[106]  J. Voges,et al.  In vivo imaging of glucose consumption and lactate concentration in human gliomas , 1992, Annals of neurology.

[107]  R. Seitz,et al.  Functional anatomy of language processing: Neuroimaging and the problem of individual variability , 1991, Neuropsychologia.

[108]  Karl J. Friston,et al.  Willed action and the prefrontal cortex in man: a study with PET , 1991, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[109]  B. Miller.  A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline , 1991, NMR in biomedicine.

[110]  M E Moseley,et al.  Comparison of diffusion‐ and T2‐weighted MRI for the early detection of cerebral ischemia and reperfusion in rats , 1991, Magnetic resonance in medicine.

[111]  D. LeBihan,et al.  Molecular diffusion nuclear magnetic resonance imaging. , 1991 .

[112]  David G. Gadian,et al.  Proton MR Spectroscopy of Intracranial Tumours: In Vivo and In Vitro Studies , 1990, Journal of computer assisted tomography.

[113]  J. Cairncross,et al.  Successful chemotherapy for newly diagnosed aggressive oligodendroglioma , 1990, Annals of neurology.

[114]  G. Ojemann,et al.  Cortical language localization in left, dominant hemisphere. An electrical stimulation mapping investigation in 117 patients. , 1989, Journal of neurosurgery.

[115]  J. Frahm,et al.  Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. , 1989, Radiology.

[116]  P. Kelly,et al.  Grading of astrocytomas: A simple and reproducible method , 1988, Cancer.

[117]  J. Cairncross,et al.  Successful chemotherapy for recurrent malignant oligodendroglioma , 1988, Annals of neurology.

[118]  G. Chiro.  Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. , 1987 .

[119]  V. Armbrustmacher,et al.  Grading of oligodendrogliomas , 1983, Cancer.

[120]  O. G. Dodge,et al.  Histological Typing of tumours of the Central Nervous System , 1981, British Journal of Cancer.

[121]  Fred H. Hochberg,et al.  Assumptions in the radiotherapy of glioblastoma , 1980, Neurology.

[122]  M. Walker,et al.  An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. , 1979, International journal of radiation oncology, biology, physics.

[123]  L. J. Rubinstein,et al.  Tumours of the central nervous system , 1979, Oxford Desk Reference: Oncology.

[124]  E. Alexander,et al.  Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. , 1978, Journal of neurosurgery.

[125]  P. Rubin,et al.  The spread of glioblastoma multiforme as a determining factor in the radiation treated volume. , 1976, International journal of radiation oncology, biology, physics.